ArticleJournal of neuro-oncology2017

Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

Hanne Kuitunen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.